Description
HIV protease substrate ARVLAEA is a peptide binding epitope of the capsid CA-p2 cleavage site.
Product Unit Size | Cost | Quantity | Stock |
---|
HIV protease substrate ARVLAEA is a peptide binding epitope of the capsid CA-p2 cleavage site.
Purity | ≥98% |
---|---|
Formula | C33H59N11O10 |
Formula Wt. | 769.90 |
Solubility | Soluble in water (2 mg/mL), acetonitrile. |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
Info Sheet |
---|
Prabu-Jeyabalan M, Nalivaika E, Schiffer CA. How does a symmetric dimer recognize an asymmetric substrate? A substrate complex of HIV-1 protease. J Mol Biol. 2000 Sep 1;301(5):1207-20. PMID: 10966816.
Pt-based DNA cross-linker.
AurKA/B inhibitor.
Endogenous peptide hormone, involved in feeding...
Peptide hormone, neurotensin analog found in am...
Water-soluble coenzyme, vitamin (B7) found in v...
Melanoma-associated antigen.
p110γ PI3K inhibitor.
Natural anthraquinone derivative
TRPA1 antagonist
β-lactam; penicillin binding protein inhibitor...
SIRT1/2 inhibitor.
Electron carrier used to study dehydrogenase el...
BHA derivative, antioxidative food and cosmetic...
Diterpene found in Taxus; potential microtubule...
Kavalactone originally found in Piper methystic...
PI3K and PDK1 inhibitor.
Cholesterol ester transfer protein inhibitor.
β-lactam; penicillin binding protein inhibitor...
Coumarin; VKORC1 inhibitor.
Micronuclei formation inducer, antimitotic, oxi...